# Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

> **NCT00070317** · NA · TERMINATED · sponsor: **Gynecologic Oncology Group** · enrollment: 102 (actual)

## Conditions studied

- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Squamous Cell Carcinoma
- Stage I Cervical Cancer

## Interventions

- **DRUG:** Isosulfan Blue
- **PROCEDURE:** Lymph Node Mapping
- **PROCEDURE:** Lymphangiography
- **DRUG:** Methylene Blue
- **PROCEDURE:** Radionuclide Imaging
- **PROCEDURE:** Sentinel Lymph Node Biopsy
- **RADIATION:** Technetium Tc-99m Sulfur Colloid
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT00070317
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070317, "Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00070317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*